Inhibition of Inflammatory and Bone-Resorption–Inhibitory Effects of Alendronate by Etidronate-Reference-Cited by-同舟云学术

Inhibition of Inflammatory and Bone-Resorption–Inhibitory Effects of Alendronate by Etidronate

Published:2005-05-19 Issue:6 Volume:76 Page:448-457
ISSN:0171-967X
Container-title:Calcified Tissue International
language:en
Short-container-title:Calcif Tissue Int

Author:

Funayama H.,Ohsako M.,Monma Y.,Mayanagi H.,Sugawara S.,Endo Y.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00223-004-0180-3.pdf

Reference30 articles.

1. Bisphosphonates: mechanisms of action.

2. Bonjour, JP, Rizzoli, R, Ammann, P, Chevalley, T (1994) “Bisphosphonates in clinical medicine” In: Heershe, NM, Kanis, JK (eds.), Bone and mineral research, vol. 8, Elsevier Science BV, Amsterdam, pp 205-264

3. Geddes, AD, D’Souza, SM, Ebentino, FH, Kenneth, JI (1994) “Bisphosphonates: structure-activity relationships and therapeutic implications” In: Heershe, NM, Kanis, JK (eds.), Bone and mineral research, vol. 8, elsevier Science BV, Amsterdam, pp 265-306

4. The acute-phase response after bisphosphonate administration

5. Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteonecrosis of the jaw in a patient treated with alendronate and then denosumab: A case of dramatic amelioration by minocycline and then etidronate;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-08

2. Release of Nitrogen-Containing Bisphosphonates (NBPs) from Hydroxyapatite by Non-NBPs and by Pyrophosphate;Biological and Pharmaceutical Bulletin;2021-11-01

3. Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates;YAKUGAKU ZASSHI;2020-01-01

4. Effects of Zoledronate on Local and Systemic Production of IL-1β, IL-18, and TNF-α in Mice and Augmentation by Lipopolysaccharide;Biological and Pharmaceutical Bulletin;2019-06-01

5. Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate);Biological and Pharmaceutical Bulletin;2019-02-01